# Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease

> **NCT06141070** · PHASE3 · RECRUITING · sponsor: **Vastra Gotaland Region** · enrollment: 240 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **OTHER:** Standard systemic therapy + radiotherapy
- **DRUG:** Standard systemic therapy

## Key facts

- **NCT ID:** NCT06141070
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2028-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06141070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06141070, "Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06141070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*